Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children

C M Pierce1, A Wade, Q Mok

  • 1Paediatric Intensive Care Unit, Great Ormond Street Hospital for Children, London, UK. christine.pierce@gosh-tr.nthames.nhs.uk

Intensive Care Medicine
|September 16, 2000
PubMed

Insights

Heparin-bonded (HB) central venous lines (CVLs) significantly reduce infection and thrombosis in critically ill children. This study demonstrates the effectiveness of HB CVLs in pediatric intensive care units.

Area of Science:

  • Medical research
  • Pediatric intensive care
  • Biomaterials science

Background:

  • Central venous lines (CVLs) are essential in intensive care but carry risks of thrombosis and infection.
  • Heparin bonding is a potential strategy to mitigate these risks.
  • Critically ill children are particularly vulnerable to catheter-related complications.

Purpose of the Study:

  • To evaluate the efficacy of heparin-bonded (HB) central venous lines (CVLs) in reducing catheter-related thrombosis and infection.
  • To compare outcomes between HB CVLs and non-heparin-bonded (NHB) CVLs in a pediatric intensive care setting.

Main Methods:

  • Prospective, double-blind, randomized controlled study in a tertiary pediatric intensive care unit.
  • 209 critically ill children (0-16 years) requiring a CVL were randomized to receive either HB or NHB CVLs.
  • Infection and thrombosis rates were monitored through blood cultures, ultrasound, and line cultures.

Main Results:

  • Heparin bonding was associated with a significant reduction in infections (4% vs. 33%) and thrombosis (0% vs. 8%).
  • The hazard ratio for infection with HB CVLs was 0.11 (P < 0.00005).
  • The number needed to treat for HB CVLs to prevent one episode of infection or thrombosis was 3 and 13, respectively.

Conclusions:

  • Heparin-bonded central venous lines significantly decrease the incidence of both infection and thrombosis in critically ill children.
  • The use of HB CVLs is a valuable intervention for improving safety in pediatric intensive care.
  • This study provides strong evidence supporting the routine use of HB CVLs in this patient population.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...